Table of Content

1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 STUDY SCOPE 20
1.3.1 REGIONS COVERED 20
1.3.2 PERIODIZATION CONSIDERED 21
1.4 CURRENCY CONSIDERED 21
1.5 VOLUME UNIT CONSIDERED 22
1.6 STAKEHOLDERS 23

2 RESEARCH METHODOLOGY 24
2.1 RESEARCH DATA 24
2.1.1 SECONDARY DATA 25
2.1.1.1 Key Data from Secondary Sources 25
2.1.2 PRIMARY DATA 26
2.1.2.1 Key Data from Primary Sources 26
2.2 FACTOR ANALYSIS 29
2.2.1 INTRODUCTION 29
2.2.2 DEMAND-SIDE ANALYSIS 29
2.2.3 SUPPLY-SIDE ANALYSIS 30
2.3 MARKET SIZE ESTIMATION 32
2.3.1 APPROACH ONE (BASED ON APPLICATION, BY REGION) 32
2.3.2 APPROACH TWO (BASED ON THE GLOBAL MARKET) 33
2.4 DATA TRIANGULATION 34
2.5 RESEARCH ASSUMPTIONS 35
2.6 RESEARCH LIMITATIONS 36

3 EXECUTIVE SUMMARY 37

4 PREMIUM INSIGHTS 42
4.1 ATTRACTIVE OPPORTUNITIES IN THE SPECIALTY ENZYMES MARKET 42
4.2 SPECIALTY ENZYMES MARKET: MAJOR REGIONAL SUBMARKETS 43
4.3 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION AND KEY COUNTRY 44
4.4 SPECIALTY ENZYMES MARKET, BY TYPE AND REGION 45
4.5 SPECIALTY ENZYMES MARKET, BY APPLICATION 46
?

5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 YC-YCC SHIFT 48
5.3 ROLE OF SPECIALTY ENZYMES IN COMBATING THE COVID-19 (CORONAVIRUS) PANDEMIC 48
5.3.1 BROAD-SPECTRUM ANTIVIRAL ADVANCEMENTS TO COMBAT CORONAVIRUS 48
5.3.1.1 ADP-ribosylation-based developments could be a potential vaccine component 49
5.3.1.2 Real-time reverse-transcription-polymerases chain reaction assay for COVID-19 has been developed and used in clinics 49
5.4 VALUE CHAIN 49
5.5 MARKET DYNAMICS 50
5.5.1 DRIVERS 51
5.5.1.1 Rise in Demand for Non-harmful Biological Catalysts in Pharmaceuticals & Diagnostics 51
5.5.1.2 Advanced Tools to Optimize Pharmaceutical Production 52
5.5.2 RESTRAINTS 53
5.5.2.1 Lack of Harmonization in the Regulatory Framework 53
5.5.2.2 High Adoption Costs involved for Small & Medium Enterprises 53
5.5.3 OPPORTUNITIES 54
5.5.3.1 Alternative to Chemical Catalysts 54
5.5.3.2 Technological Innovations and Wide Industry Scope 54
5.5.3.3 Launching Enzymes with Long Shelf life 55
5.5.3.3.1 Encapsulation to enhance shelf life 55
5.5.4 CHALLENGES 56
5.5.4.1 High Raw Material Costs Limiting Enzyme Usage 56
5.5.4.2 Concern Over Quality of Enzymes Used in Pharmaceuticals & Diagnostics 56

6 PATENT ANALYSIS 57
6.1 INTRODUCTION 57

7 SPECIALTY ENZYMES MARKET, BY TYPE 62
7.1 INTRODUCTION 63
7.2 CARBOHYDRASES 65
7.2.1 AMYLASES 66
7.2.2 CELLULASES 67
7.2.3 OTHER CARBOHYDRASES 67
7.3 PROTEASES 68
7.3.1 COMPETENT CHARACTERISTIC TO HYDROLYZE THE PROTEINS IS USED IN DIAGNOSTICS TO REVERSE THE PROGRESSION OF THE DISEASE 68
7.4 LIPASES 69
7.4.1 RISE IN DEMAND AMONG PHARMACEUTICAL MANUFACTURERS AS LIPASES ADMINISTRATE ENZYME DEFICIENCIES IN HUMANS 69
7.5 POLYMERASES & NUCLEASES 70
7.5.1 POLYMERASES & NUCLEASES FORM AN ESSENTIAL PART FOR ALL NUCLEIC ACID PROCESSES 70
7.6 OTHER ENZYMES 71
7.6.1 FUNCTIONAL BENEFITS IN VARIOUS APPLICATIONS HAVE BEEN DRIVING THE MARKET FOR OTHER ENZYMES 71

8 SPECIALTY ENZYMES MARKET, BY APPLICATION 73
8.1 INTRODUCTION 74
8.2 PHARMACEUTICALS 75
8.2.1 ENZYMES ACT AS AN ALTERNATIVE TO TRADITIONAL ANTIBIOTICS 75
8.3 RESEARCH & BIOTECHNOLOGY 76
8.3.1 USE OF ENZYMES IN DNA SEQUENCING REDUCES THE COST FOR SEQUENCING TECHNIQUES 76
8.4 DIAGNOSTICS 78
8.4.1 DIAGNOSING LIFE-THREATENING DISEASES AT AN INITIAL STAGE DRIVES THE DEMAND FOR SPECIALTY ENZYMES 78
8.5 BIOCATALYSTS 79
8.5.1 BIOCATALYSIS IS A PROMISING TECHNOLOGY IN WASTE MATERIAL TREATMENT 79

9 SPECIALTY ENZYMES MARKET, BY SOURCE 81
9.1 INTRODUCTION 82
9.2 MICROORGANISMS 83
9.2.1 HUGE PRODUCTION IN LESSER TIME BOOSTS THE INDUSTRIAL USAGE OF MICROBIAL ENZYMES 83
9.3 PLANTS 84
9.3.1 PLANT-BASED ENZYMES THRIVE OVER A WIDE RANGE OF TEMPERATURES 84
9.4 ANIMALS 85
9.4.1 BEING TEMPERATURE-SENSITIVE DISCOURAGES THE INDUSTRIAL USAGE OF ANIMAL-BASED ENZYMES 85

10 SPECIALTY ENZYMES MARKET, BY FORM 86
10.1 INTRODUCTION 86
10.2 LIQUID 86
10.2.1 EASE OF USE IN THE DIAGNOSTIC INDUSTRY BOOSTS THE USAGE OF THE LIQUID FORM 86
10.3 DRY 87
10.3.1 DRY FORM ENABLES A BETTER ACCURACY OF DOSAGES 87
?

11 SPECIALTY ENZYMES MARKET, BY REGION 88
11.1 INTRODUCTION 89
11.2 NORTH AMERICA 90
11.2.1 US 94
11.2.1.1 Increasing awareness among manufacturers pertaining to the enhanced product quality with the usage of enzymes to drive the market growth in the US 94
11.2.2 CANADA 95
11.2.2.1 Enzymes usage has witnessed an increase in demand in cancer diagnosis 95
11.2.3 MEXICO 97
11.2.3.1 Enzymes can be used in diagnostics to detect the changes in the substrate concentrations 97
11.3 EUROPE 98
11.3.1 ITALY 103
11.3.1.1 Rise in production in the pharmaceutical industry could increase the demand for specialty enzymes 103
11.3.2 GERMANY 104
11.3.2.1 Rise in research & development involved in the pharmaceutical industry drives the demand for enzymes 104
11.3.3 FRANCE 105
11.3.3.1 Rise in clinical developments would impact the French biotechnology industry and increase the usage of specialty enzymes 105
11.3.4 SPAIN 106
11.3.4.1 Spanish government’s emphasis on developments in the pharmaceutical industry resulting in boosting the enzymes market 106
11.3.5 UK 107
11.3.5.1 Enzymes used in the drug cloning technique could boost the market for specialty enzymes 107
11.3.6 REST OF EUROPE 108
11.3.6.1 Growth in the pharmaceutical industry in most European countries driving the specialty enzymes market 108
11.4 ASIA PACIFIC 109
11.4.1 CHINA 114
11.4.1.1 Technical advancements augmenting the demand for specialty enzymes in China 114
11.4.2 INDIA 115
11.4.2.1 The rising demand in the pharmaceutical industry would boost the specialty enzymes market 115
11.4.3 JAPAN 116
11.4.3.1 Growing biotechnology advancements in Japan would augment the demand for specialty enzymes 116
11.4.4 AUSTRALIA & NEW ZEALAND 117
11.4.4.1 Favorable government regulations would increase biotechnology advancements, which would result in the rise in specialty enzymes usage 117
11.4.5 REST OF ASIA PACIFIC 118
11.4.5.1 Developing countries in the Asia Pacific region present immense scope for the enzymes industry 118
11.5 REST OF THE WORLD 119
11.5.1 BRAZIL 123
11.5.1.1 The emerging pharmaceutical industry in Brazil driving the demand for enzymes 123
11.5.2 ARGENTINA 124
11.5.2.1 Technological pharmaceutical advancements would boost the market for enzymes 124
11.5.3 SOUTH AFRICA 125
11.5.3.1 Rising demand for generic medicines boosts growth in the South African pharmaceutical industry 125
11.5.4 OTHERS IN ROW 126
11.5.4.1 Biotechnological advancements in African nations drive the market for specialty enzymes 126
12 COMPETITIVE LANDSCAPE 127
12.1 INTRODUCTION 127
12.2 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) 128
12.2.1 VISIONARY LEADERS 128
12.2.2 DYNAMIC DIFFERENTIATORS 128
12.2.3 INNOVATORS 128
12.2.4 EMERGING COMPANIES 128
12.3 RANKING OF KEY PLAYERS, 2018 130
12.4 STRENGTH OF PRODUCT PORTFOLIO (OVERALL MARKET) 131
12.5 BUSINESS STRATEGY EXCELLENCE (OVERALL MARKET) 132
12.6 COMPETITIVE SCENARIO 133
12.6.1 EXPANSIONS & INVESTMENTS 133
12.6.2 AGREEMENTS, COLLABORATIONS, AND JOINT VENTURES 134
12.6.3 NEW PRODUCT LAUNCHES 135
12.6.4 ACQUISITIONS 136
12.7 COMPETITIVE LEADERSHIP MAPPING (START-UP/SME) 136
12.7.1 PROGRESSIVE COMPANIES 136
12.7.2 STARTING BLOCKS 136
12.7.3 RESPONSIVE COMPANIES 136
12.7.4 DYNAMIC COMPANIES 137
12.8 STRENGTH OF PRODUCT PORTFOLIO (STARTUP/SME) 138
12.9 BUSINESS STRATEGY EXCELLENCE (STARTUP/SME) 138
?
13 COMPANY PROFILES 139
(Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)*
13.1 BASF 139
13.2 NOVOZYMES 142
13.3 ROCHE HOLDING 144
13.4 DUPONT 146
13.5 CODEXIS 149
13.6 DYADIC INTERNATIONAL 152
13.7 ADVANCED ENZYMES 154
13.8 AMANO ENZYME 156
13.9 SANOFI 157
13.10 BIOCATALYSTS 159
13.11 ENZYME SUPPLIES 160
13.12 BBI SOLUTIONS 161
13.13 SPECIALTY ENZYMES & PROBIOTICS 162
13.14 AMICOGEN 163
13.15 ANTOZYME BIOTECH 165
13.16 ENZYME DEVELOPMENT CORPORATION 166
13.17 NAGASE & CO. LTD. 167
13.18 SEKISUI DIAGNOSTICS 168
13.19 MERCK KGAA 169
13.20 BIOVET 171
*Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
14 APPENDIX 172
14.1 DISCUSSION GUIDE 172
14.2 KNOWLEDGE STORE 177
14.3 AVAILABLE CUSTOMIZATIONS 179
14.4 RELATED REPORTS 179
14.5 AUTHOR DETAILS 180



List of Figures



FIGURE 1 MARKET SEGMENTATION 20
FIGURE 2 SPECIALTY ENZYMES MARKET: RESEARCH DESIGN 24
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION AND REGION 28
FIGURE 4 GDP GROWTH OF KEY ECONOMIES, 2013–2018 (USD TRILLION) 30
FIGURE 6 DATA TRIANGULATION METHODOLOGY 34
FIGURE 7 SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2019 VS. 2025 (USD MILLION) 38
FIGURE 8 SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2019 VS. 2025 (TON) 38
FIGURE 9 SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2019 VS. 2025 (USD MILLION) 39
FIGURE 10 SPECIALTY ENZYMES MARKET SIZE, BY SOURCE, 2019 VS. 2025 (USD MILLION) 40
FIGURE 11 SPECIALTY ENZYMES MARKET SHARE (VALUE), BY REGION, 2018 41
FIGURE 12 GROWING DEMAND FOR PHARMACEUTICAL PRODUCTS IS PROJECTED TO DRIVE THE GROWTH OF THE SPECIALTY ENZYMES MARKET 42
FIGURE 13 US WAS THE LARGEST MARKET GLOBALLY FOR SPECIALTY ENZYMES IN 2018 43
FIGURE 14 US ACCOUNTED FOR THE LARGEST SHARE IN THE NORTH AMERICAN MARKET
IN 2018 44
FIGURE 15 NORTH AMERICA IS PROJECTED TO DOMINATE THE MARKET FOR SPECIALTY ENZYMES, 2019 VS. 2025 45
FIGURE 16 THE PHARMACEUTICALS SEGMENT IS PROJECTED TO DOMINATE THE SPECIALTY ENZYMES MARKET DURING THE FORECAST PERIOD, 2019 VS. 2025 46
FIGURE 17 SPECIALTY ENZYMES MARKET: VALUE CHAIN 50
FIGURE 18 SPECIALTY ENZYMES MARKET DYNAMICS 50
FIGURE 19 FOOD DIAGNOSTICS MARKET SIZE, BY REGION, 2016–2023 (USD BILLION) 51
FIGURE 20 INDIA: REVENUE OF THE PHARMACEUTICAL SECTOR, 2016–2019 (USD BILLION) 52
FIGURE 21 GLOBAL EXPENDITURE ON R&D, 2015–2018 (USD MILLION) 55
FIGURE 22 PATENT INSIGHTS 57
FIGURE 23 SPECIALTY ENZYMES MARKET SHARE (VALUE), BY TYPE, 2019 VS. 2025 63
FIGURE 24 SPECIALTY ENZYMES MARKET SHARE (VALUE), BY APPLICATION, 2019 VS. 2025 74
FIGURE 25 SPECIALTY ENZYMES MARKET SHARE (VALUE), BY SOURCE, 2019 VS. 2025 82
FIGURE 26 FLOW CHART FOR THE PRODUCTION OF DRY ENZYMES 87
FIGURE 27 SPECIALTY ENZYMES MARKET GROWTH, BY KEY COUNTRY, 2019–2025 89
FIGURE 28 NORTH AMERICA: SPECIALTY ENZYMES MARKET SNAPSHOT 91
FIGURE 29 EUROPE: SPECIALTY ENZYMES MARKET SNAPSHOT, 2018 99
FIGURE 30 ASIA PACIFIC: SPECIALTY ENZYMES MARKET SNAPSHOT 110
FIGURE 31 SPECIALTY ENZYMES MARKET (OVERALL MARKET):
COMPETITIVE LEADERSHIP MAPPING, 2018 129
FIGURE 32 BASF LED THE SPECIALTY ENZYMES MARKET IN 2018 130
FIGURE 33 PRODUCT PORTFOLIO ANALYSIS OF TOP PLAYERS IN (OVERALL MARKET) SPECIALTY ENZYMES MARKET 131
FIGURE 34 BUSINESS STRATEGY EXCELLENCE OF TOP PLAYERS IN (OVERALL MARKET) SPECIALTY ENZYMES MARKET 132
FIGURE 35 SPECIALTY ENZYMES MARKET (START-UP/SME):
COMPETITIVE LEADERSHIP MAPPING, 2018 137
FIGURE 36 PRODUCT PORTFOLIO ANALYSIS OF TOP PLAYERS IN (STARTUP/SME) SPECIALTY ENZYMES MARKET 138
FIGURE 37 BUSINESS STRATEGY EXCELLENCE OF TOP PLAYERS IN (STARTUP/SME) SPECIALTY ENZYMES MARKET 138
FIGURE 38 BASF: COMPANY SNAPSHOT 139
FIGURE 39 BASF: SWOT ANALYSIS 141
FIGURE 40 NOVOZYMES: COMPANY SNAPSHOT 142
FIGURE 41 NOVOZYMES: SWOT ANALYSIS 143
FIGURE 42 ROCHE HOLDING: COMPANY SNAPSHOT 144
FIGURE 43 ROCHE HOLDING: SWOT ANALYSIS 145
FIGURE 44 DUPONT: COMPANY SNAPSHOT 146
FIGURE 45 DUPONT: SWOT ANALYSIS 147
FIGURE 46 CODEXIS: COMPANY SNAPSHOT 149
FIGURE 47 CODEXIS: SWOT ANALYSIS 151
FIGURE 48 DYADIC INTERNATIONAL: COMPANY SNAPSHOT 152
FIGURE 49 ADVANCED ENZYMES: COMPANY SNAPSHOT 154
FIGURE 50 SANOFI: COMPANY SNAPSHOT 157
FIGURE 51 AMICOGEN: COMPANY SNAPSHOT 163
FIGURE 52 NAGASE & CO. LTD.: COMPANY SNAPSHOT 167
FIGURE 53 MERCK KGAA: COMPANY SNAPSHOT 169

 

List of Tables



TABLE 1 USD EXCHANGE RATES CONSIDERED, 2014–2019 22
TABLE 2 SPECIALTY ENZYMES MARKET SNAPSHOT, 2019 VS. 2025 37
TABLE 3 PATENTS PERTAINING TO ENZYMES, 2017–2020 58
TABLE 4 SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION) 64
TABLE 5 SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (TON) 64
TABLE 6 CARBOHYDRASES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION) 65
TABLE 7 CARBOHYDRASES MARKET SIZE, BY SUBTYPE, 2017–2025 (USD MILLION) 65
TABLE 8 CARBOHYDRASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION) 66
TABLE 9 AMYLASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION) 66
TABLE 10 CELLULASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION) 67
TABLE 11 OTHER CARBOHYDRASES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 68
TABLE 12 PROTEASES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION) 68
TABLE 13 PROTEASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION) 69
TABLE 14 LIPASES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION) 69
TABLE 15 LIPASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION) 70
TABLE 16 POLYMERASES & NUCLEASES MARKET SIZE, BY REGION 2017–2025 (USD MILLION) 70
TABLE 17 POLYMERASES & NUCLEASES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 71
TABLE 18 OTHER ENZYMES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION) 71
TABLE 19 OTHER ENZYMES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION) 72
TABLE 20 SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION) 74
TABLE 21 SPECIALTY ENZYMES MARKET SIZE IN PHARMACEUTICALS, BY REGION 2017–2025 (USD MILLION) 75
TABLE 22 SPECIALTY ENZYMES MARKET SIZE IN PHARMACEUTICALS, BY TYPE 2017–2025 (USD MILLION) 76
TABLE 23 SPECIALTY ENZYMES MARKET SIZE IN RESEARCH & BIOTECHNOLOGY, BY REGION, 2017–2025 (USD MILLION) 77
TABLE 24 SPECIALTY ENZYMES MARKET SIZE IN RESEARCH & BIOTECHNOLOGY, BY TYPE, 2017–2025 (USD MILLION) 77
TABLE 25 SPECIALTY ENZYMES MARKET SIZE IN DIAGNOSTICS, BY REGION 2017–2025 (USD MILLION) 78
TABLE 26 SPECIALTY ENZYMES MARKET SIZE IN DIAGNOSTICS, BY TYPE 2017–2025 (USD MILLION) 79
TABLE 27 SPECIALTY ENZYMES MARKET SIZE IN BIOCATALYSTS, BY REGION 2017–2025 (USD MILLION) 80
TABLE 28 SPECIALTY ENZYMES MARKET SIZE IN BIOCATALYSTS, BY TYPE 2017–2025 (USD MILLION) 80
TABLE 29 SPECIALTY ENZYMES MARKET SIZE, BY SOURCE, 2017–2025 (USD MILLION) 82
TABLE 30 MICROORGANISM-BASED SPECIALTY ENZYMES MARKET SIZE, BY REGION 2017–2025 (USD MILLION) 83
TABLE 31 PLANT-BASED SPECIALTY ENZYMES MARKET SIZE, BY REGION 2017–2025 (USD MILLION) 84
TABLE 32 ANIMAL-BASED SPECIALTY ENZYMES MARKET SIZE, BY REGION 2017–2025 (USD MILLION) 85
TABLE 33 SPECIALTY ENZYMES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION) 90
TABLE 34 NORTH AMERICA: SPECIALTY ENZYMES MARKET SIZE, BY COUNTRY 2017–2025 (USD MILLION) 91
TABLE 35 NORTH AMERICA: SPECIALTY ENZYMES MARKET SIZE FOR PHARMACEUTICALS BY COUNTRY, 2017–2025 (USD MILLION) 92
TABLE 36 NORTH AMERICA: SPECIALTY ENZYMES MARKET SIZE FOR RESEARCH & BIOTECHNOLOGY, BY COUNTRY, 2017–2025 (USD MILLION) 92
TABLE 37 NORTH AMERICA: SPECIALTY ENZYMES MARKET SIZE FOR DIAGNOSTICS BY COUNTRY, 2017–2025 (USD MILLION) 92
TABLE 38 NORTH AMERICA: SPECIALTY ENZYMES MARKET SIZE FOR BIOCATALYSTS BY COUNTRY, 2017–2025 (USD MILLION) 93
TABLE 39 NORTH AMERICA: SPECIALTY ENZYMES MARKET SIZE, BY TYPE 2017–2025 (USD MILLION) 93
TABLE 40 NORTH AMERICA: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (TON) 93
TABLE 41 NORTH AMERICA: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 94
TABLE 42 NORTH AMERICA: ENZYMES MARKET SIZE, BY SOURCE 2017–2025 (USD MILLION) 94
TABLE 43 US: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 95
TABLE 44 US: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION) 95
TABLE 45 CANADA: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 96
TABLE 46 CANADA: SPECIALTY ENZYMES MARKET SIZE, BY TYPE 2017–2025 (USD MILLION) 96
TABLE 47 CANADA: SPECIALTY ENZYMES MARKET SIZE, BY TYPE 2017–2025 (USD MILLION) 96
TABLE 48 MEXICO: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 97
TABLE 49 MEXICO: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION) 97
TABLE 50 EUROPE: SPECIALTY ENZYMES MARKET SIZE, BY COUNTRY 2017–2025 (USD MILLION) 100
TABLE 51 EUROPE: SPECIALTY ENZYMES MARKET SIZE FOR PHARMACEUTICALS BY COUNTRY, 2017–2025 (USD MILLION) 100
TABLE 52 EUROPE: SPECIALTY ENZYMES MARKET SIZE FOR RESEARCH & BIOTECHNOLOGY, BY COUNTRY, 2017–2025 (USD MILLION) 101
TABLE 53 EUROPE: SPECIALTY ENZYMES MARKET SIZE FOR DIAGNOSTICS, BY COUNTRY, 2017–2025 (USD MILLION) 101
TABLE 54 EUROPE: SPECIALTY ENZYMES MARKET SIZE FOR BIOCATALYSTS, BY COUNTRY, 2017–2025 (USD MILLION) 102
TABLE 55 EUROPE: SPECIALTY ENZYMES MARKET SIZE, BY TYPE 2017–2025 (USD MILLION) 102
TABLE 56 EUROPE: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (TONS) 102
TABLE 57 EUROPE: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 103
TABLE 58 EUROPE: ENZYMES MARKET SIZE, BY SOURCE, 2017–2025 (USD MILLION) 103
TABLE 59 ITALY: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 104
TABLE 60 ITALY: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION) 104
TABLE 61 GERMANY: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 105
TABLE 62 GERMANY: SPECIALTY ENZYMES MARKET SIZE, BY TYPE 2017–2025 (USD MILLION) 105
TABLE 63 FRANCE: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 106
TABLE 64 FRANCE: SPECIALTY ENZYMES MARKET SIZE, BY TYPE 2017–2025 (USD MILLION) 106
TABLE 65 SPAIN: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 107
TABLE 66 SPAIN: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION) 107
TABLE 67 UK: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 108
TABLE 68 UK: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION) 108
TABLE 69 REST OF EUROPE: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 109
TABLE 70 REST OF EUROPE: SPECIALTY ENZYMES MARKET SIZE, BY TYPE 2017–2025 (USD MILLION) 109
TABLE 71 ASIA PACIFIC: SPECIALTY ENZYMES MARKET SIZE, BY COUNTRY/REGION 2017–2025 (USD MILLION) 111
TABLE 72 ASIA PACIFIC: SPECIALTY ENZYMES MARKET SIZE FOR PHARMACEUTICALS BY COUNTRY/REGION, 2017–2025 (USD MILLION) 111
TABLE 73 ASIA PACIFIC: SPECIALTY ENZYMES MARKET SIZE FOR RESEARCH & BIOTECHNOLOGY, BY COUNTRY/REGION, 2017–2025 (USD MILLION) 112
TABLE 74 ASIA PACIFIC: SPECIALTY ENZYMES MARKET SIZE FOR DIAGNOSTICS BY COUNTRY/REGION, 2017–2025 (USD MILLION) 112
TABLE 75 ASIA PACIFIC: SPECIALTY ENZYMES MARKET SIZE FOR BIOCATALYSTS BY COUNTRY/REGION, 2017–2025 (USD MILLION) 113
TABLE 76 ASIA PACIFIC: SPECIALTY ENZYMES MARKET SIZE, BY TYPE 2017–2025 (USD MILLION) 113
TABLE 77 ASIA PACIFIC: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (TONS) 113
TABLE 78 ASIA PACIFIC: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 114
TABLE 79 ASIA PACIFIC: ENZYMES MARKET SIZE, BY SOURCE, 2017–2025 (USD MILLION) 114
TABLE 80 CHINA: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 115
TABLE 81 CHINA: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION) 115
TABLE 82 INDIA: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 116
TABLE 83 INDIA: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION) 116
TABLE 84 JAPAN: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 117
TABLE 85 JAPAN: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION) 117
TABLE 86 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET SIZE BY APPLICATION, 2017–2025 (USD MILLION) 118
TABLE 87 AUSTRALIA & NEW ZEALAND: SPECIALTY ENZYMES MARKET SIZE, BY TYPE 2017–2025 (USD MILLION) 118
TABLE 88 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION) 119
TABLE 89 REST OF ASIA PACIFIC: SPECIALTY ENZYMES MARKET SIZE, BY TYPE 2017–2025 (USD MILLION) 119
TABLE 90 ROW: SPECIALTY ENZYMES MARKET SIZE, BY COUNTRY 2017–2025 (USD MILLION) 120
TABLE 91 ROW: SPECIALTY ENZYMES MARKET SIZE FOR PHARMACEUTICALS, BY COUNTRY, 2017–2025 (USD MILLION) 120
TABLE 92 ROW: SPECIALTY ENZYMES MARKET SIZE FOR RESEARCH & BIOTECHNOLOGY BY COUNTRY, 2017–2025 (USD MILLION) 120
TABLE 93 ROW: SPECIALTY ENZYMES MARKET SIZE FOR DIAGNOSTICS, BY COUNTRY 2017–2025 (USD MILLION) 121
TABLE 94 ROW: SPECIALTY ENZYMES MARKET SIZE FOR BIOCATALYSTS, BY COUNTRY, 2017–2025 (USD MILLION) 121
TABLE 95 ROW: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION) 121
TABLE 96 ROW: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (TON) 122
TABLE 97 ROW: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 122
TABLE 98 ROW: ENZYMES MARKET SIZE, BY SOURCE, 2017–2025 (USD MILLION) 122
TABLE 99 BRAZIL: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 123
TABLE 100 BRAZIL: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION) 123
TABLE 101 ARGENTINA: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 124
TABLE 102 ARGENTINA: SPECIALTY ENZYMES MARKET SIZE, BY TYPE 2017–2025 (USD MILLION) 124
TABLE 103 SOUTH AFRICA: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 125
TABLE 104 SOUTH AFRICA: SPECIALTY ENZYMES MARKET SIZE, BY TYPE 2017–2025 (USD MILLION) 125
TABLE 105 OTHERS IN ROW: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION 2017–2025 (USD MILLION) 126
TABLE 106 OTHERS IN ROW: SPECIALTY ENZYMES MARKET SIZE, BY TYPE 2017–2025 (USD MILLION) 126
TABLE 107 EXPANSIONS & INVESTMENTS, 2017–2019 133
TABLE 108 AGREEMENTS, COLLABORATIONS, AND JOINT VENTURES, 2017–2019 134
TABLE 109 NEW PRODUCT LAUNCHES, 2017–2019 135
TABLE 110 ACQUISITIONS, 2017–2019 136